Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Are natural killer cells the key to treating Epstein-Barr virus-associated lymphoproliferative disorders?

× No keyword cloud information.

20 in total

Review 1. Epstein-Barr virus infection.

Authors: J I Cohen
Journal: N Engl J Med Date: 2000-08-17 Impact factor: 91.245

Review 2. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection.

Authors: A B Rickinson; D J Moss
Journal: Annu Rev Immunol Date: 1997 Impact factor: 28.527

3. Durable remission after aggressive chemotherapy for very late post-kidney transplant lymphoproliferation: A report of 16 cases observed in a single center.

Authors: M F Mamzer-Bruneel; C Lomé; E Morelon; V Levy; P Bourquelot; F Jacobs; A Gessain; E Mac Intyre; N Brousse; H Kreis; O Hermine
Journal: J Clin Oncol Date: 2000-11-01 Impact factor: 44.544

4. GM-CSF and IL-2 induce specific cellular immunity and provide protection against Epstein-Barr virus lymphoproliferative disorder.

Authors: R A Baiocchi; J S Ward; L Carrodeguas; C F Eisenbeis; R Peng; S Roychowdhury; S Vourganti; T Sekula; M O'Brien; M Moeschberger; M A Caligiuri
Journal: J Clin Invest Date: 2001-09 Impact factor: 14.808

5. CD20 monoclonal antibody (rituximab) for therapy of Epstein-Barr virus lymphoma after hemopoietic stem-cell transplantation.

Authors: I Kuehnle; M H Huls; Z Liu; M Semmelmann; R A Krance; M K Brenner; C M Rooney; H E Heslop
Journal: Blood Date: 2000-02-15 Impact factor: 22.113

6. Posttransplantation lymphoproliferative disorders in bone marrow transplant recipients are aggressive diseases with a high incidence of adverse histologic and immunobiologic features.

Authors: A Orazi; R A Hromas; R S Neiman; T C Greiner; C H Lee; L Rubin; S Haskins; N A Heerema; V Gharpure; R Abonour; E F Srour; K Cornetta
Journal: Am J Clin Pathol Date: 1997-04 Impact factor: 2.493

7. Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients.

Authors: C M Rooney; C A Smith; C Y Ng; S K Loftin; J W Sixbey; Y Gan; D K Srivastava; L C Bowman; R A Krance; M K Brenner; H E Heslop
Journal: Blood Date: 1998-09-01 Impact factor: 22.113

Are natural killer cells the key to treating Epstein-Barr virus-associated lymphoproliferative disorders?